Item 7A. Quantitative and Qualitative Disclosures About Market Risk
ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
General
We
are required to make certain disclosures regarding our financial instruments, including derivatives, if any.
A
financial instrument is defined as cash, evidence of an ownership interest in an entity, or a contract that imposes on one entity a contractual
obligation either to deliver or receive cash or another financial instrument to or from a second entity. Examples of financial instruments
include cash and cash equivalents, deposits, trade accounts receivable, loans, investments, trade accounts payable, accrued expenses,
options and forward contracts. The disclosures below include, among other matters, the nature and terms of derivative transactions, information
about significant concentrations of credit risk, and the fair value of financial assets and liabilities.
Fair
Value of Financial Instruments
Fair
values of financial instruments included in current assets and current liabilities are estimated to approximate their book values due
to the short maturity of such investments.
Concentrations
of Credit Risk
The
Company’s financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of
cash and trade accounts receivable. The Company’s cash was deposited with a U.S. bank and amounted to approximately $1,722,000
at December 31, 2021. The Company did not have any one customer that represented at least 10% of its accounts receivable at December
31, 2021. Credit risk with respect to the balance of trade receivables is generally diversified due to the number of entities comprising
the Company’s customer base. The Company does not believe there is significant risk of non-performance by these counterparties.
Interest
Rate Risk
In
March 2019, OmniMetrix reinstated its loan and security agreement which provided OmniMetrix with access to accounts receivable formula-based
financing of the lesser of 75% of eligible receivables or $1 million. Debt incurred under this financing arrangement bore interest at
the greater of 6% and prime plus 1.5% per year. In addition, OmniMetrix paid a monthly service charge of 0.75% of the average aggregate
principal amount outstanding for the prior month, for an effective rate of interest on advances of 15%. OmniMetrix also agreed to maintain
a minimum loan balance of $150,000 in its line-of-credit with the lender for a minimum of two years beginning March 1, 2019. From time
to time, the balance outstanding fell below $150,000 based on collections applied against the loan balance and the timing of loan draws.
We elected not to renew this line of credit and allowed it to expire in accordance with its terms on February 28, 2021. OmniMetrix no
longer has interest rate risk related to debt.
COVID-19
Pandemic Risk to Supply Chain
As
discussed above under the “RISK FACTORS” heading, the COVID-19 pandemic could substantially interfere with general commercial
activity related to our supply chain and customer base, which could have a material adverse effect on our financial condition, results
of operations, business, or prospects. Some of the electronic devices and hardware we purchase, like antennas, radios, and GPS modules
are very specific to our application; and there are not likely to be practical alternatives. In some cases, our circuit boards were designed
around specific electronic hardware that met our specifications. We continue to work closely with our contract manufacturers and suppliers
in order to mitigate, as much as possible, the risks to our supply chain for these critical devices and hardware, including identifying
any lead-time issues and any potential alternate sources. We also continue to examine all currently open purchase orders in an effort
to identify whether we need to issue additional orders to secure product that is critical, already has questionable lead times and/or
is unique to our requirements. Alternate sources may not be available or may result in delays in shipments to us from our supply chain
and subsequently to our customers, each of which would affect our results of operations. Further, if our customers’ businesses
are similarly affected as a result of the pandemic, they might delay or reduce purchases from us, which could adversely affect our results
of operations.
ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Furnished
at the end of this report commencing on page F-1.
ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.